相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses
Yi-Qian Sun et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
Ki-Chul Sung et al.
JOURNAL OF CLINICAL MEDICINE (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy et al.
CIRCULATION (2019)
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering A Systematic Review and Meta-analysis
Eliano P. Navarese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Association of change in total cholesterol level with mortality: A population-based study
Su-Min Jeong et al.
PLOS ONE (2018)
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study
Shuaib M. Abdullah et al.
CIRCULATION (2018)
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality inmen and women: two prospective cohort studies
Christian M. Madsen et al.
EUROPEAN HEART JOURNAL (2017)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization
James R. Staley et al.
GENETIC EPIDEMIOLOGY (2017)
Extent of undertreatment and overtreatment with cholesterollowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014
Anne Langsted et al.
ATHEROSCLEROSIS (2017)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
Instrumental Variable Analysis with a Nonlinear Exposure-Outcome Relationship
Stephen Burgess et al.
EPIDEMIOLOGY (2014)
Association of lipoprotein levels with mortality in subjects aged 50+without previous diabetes or cardiovascular disease: A population-based register study
Lise Bathum et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2013)
Multiple imputation using chained equations: Issues and guidance for practice
Ian R. White et al.
STATISTICS IN MEDICINE (2011)
Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds
Line Kirkeby Petersen et al.
AGE AND AGEING (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders
Jennifer L. Akerblom et al.
AGE AND AGEING (2008)
Correcting biases in estimates of mortality attributable to obesity
James A. Greenberg
OBESITY (2006)
Low-density lipoprotein cholesterol and mortality in older people
V Tikhonoff et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Relationship between plasma lipids and all-cause mortality in nondemented elderly
N Schupf et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study
BM Psaty et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
分享论文
